Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors-Reference-Cited by-同舟云学术

Single‐domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitors

Published:2020-03-11 Issue:4 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Barbon Elena¹^ORCID,Ayme Gabriel²,Mohamadi Amel²,Ottavi Jean‐François³,Kawecki Charlotte²,Casari Caterina²,Verhenne Sebastien²,Marmier Solenne¹,van Wittenberghe Laetitia¹,Charles Severine¹,Collaud Fanny¹,Denis Cecile V²,Christophe Olivier D²,Mingozzi Federico¹^ORCID,Lenting Peter J²^ORCID

Affiliation:

1. Genethon, Institut National de la Santé et de la Recherche Médicale U951 Integrare Université Paris‐Saclay University of Evry Evry France

2. HITh, UMR_S1176 Institut National de la Santé et de la Recherche Médicale Université Paris‐Saclay Le Kremlin‐Bicêtre France

3. Inovarion Paris France

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201911298

Reference56 articles.

1. D-dimer antigen: current concepts and future prospects

2. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies

3. A Novel Single-Domain Antibody Against von Willebrand Factor A1 Domain Resolves Leukocyte Recruitment and Vascular Leakage During Inflammation—Brief Report

4. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency

5. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Murine models of hemostasis;HEMATOLOGIE;2023

2. The use of peptides, aptamers, and variable domains of heavy chain only antibodies in tissue engineering and regenerative medicine;Acta Biomaterialia;2023-10

3. RNAi for the Treatment of People with Hemophilia: Current Evidence and Patient Selection;Journal of Blood Medicine;2023-04

4. Nanobodies: Robust miniprotein binders in biomedicine;Advanced Drug Delivery Reviews;2023-04

5. New directions to develop therapies for people with hemophilia;Expert Review of Hematology;2023-03-08